SFTPD and asthma: In keeping with the studies discussed above on the suppressive effects of SP-D on responses to A. fumigatus allergens, intranasal treatment of mice with invasive pulmonary aspergillosis with SP-D or rhSP-D markedly reduced mortality over a period of 15 days (169), suggesting its possible therapeutic use in the treatment of allergic responses or asthma.